Morjani H - Search Results

1

Telomestatin-induced telomere uncapping is modulated by POT1 through G-overhang extension in HT1080 human tumor cells.

Gomez D, Wenner T, Brassart B, Douarre C, O'Donohue MF, El Khoury V, Shin-Ya K, Morjani H, Trentesaux C, Riou JF. Gomez D, et al. Among authors: morjani h. J Biol Chem. 2006 Dec 15;281(50):38721-9. doi: 10.1074/jbc.M605828200. Epub 2006 Oct 17. J Biol Chem. 2006. PMID: 17050546 Free article.

2

Molecular and cellular interactions between intoplicine, DNA, and topoisomerase II studied by surface-enhanced Raman scattering spectroscopy.

Morjani H, Riou JF, Nabiev I, Lavelle F, Manfait M. Morjani H, et al. Cancer Res. 1993 Oct 15;53(20):4784-90. Cancer Res. 1993. PMID: 8402662

3

Intracellular molecular interactions of antitumor drug amsacrine (m-AMSA) as revealed by surface-enhanced Raman spectroscopy.

Chourpa I, Morjani H, Riou JF, Manfait M. Chourpa I, et al. Among authors: morjani h. FEBS Lett. 1996 Nov 11;397(1):61-4. doi: 10.1016/s0014-5793(96)01141-6. FEBS Lett. 1996. PMID: 8941714 Free article.

4

Resistance to the short term antiproliferative activity of the G-quadruplex ligand 12459 is associated with telomerase overexpression and telomere capping alteration.

Gomez D, Aouali N, Londoño-Vallejo A, Lacroix L, Mégnin-Chanet F, Lemarteleur T, Douarre C, Shin-ya K, Mailliet P, Trentesaux C, Morjani H, Mergny JL, Riou JF. Gomez D, et al. Among authors: morjani h. J Biol Chem. 2003 Dec 12;278(50):50554-62. doi: 10.1074/jbc.M308440200. Epub 2003 Oct 2. J Biol Chem. 2003. PMID: 14525974 Free article.

5

Resistance to senescence induction and telomere shortening by a G-quadruplex ligand inhibitor of telomerase.

Gomez D, Aouali N, Renaud A, Douarre C, Shin-Ya K, Tazi J, Martinez S, Trentesaux C, Morjani H, Riou JF. Gomez D, et al. Among authors: morjani h. Cancer Res. 2003 Oct 1;63(19):6149-53. Cancer Res. 2003. PMID: 14559794

6

[Regulation of telomeres length: making the telomeres accessible?].

Riou JF, Gomez D, Mergny JL, Guittat L, Paterski R, Chenais B, Morjani H, Trentesaux C. Riou JF, et al. Among authors: morjani h. Bull Cancer. 2005 Jan;92(1):13-22. Bull Cancer. 2005. PMID: 15811846 Free article. Review. French.

7

Overexpression of Bcl-2 is associated with apoptotic resistance to the G-quadruplex ligand 12459 but is not sufficient to confer resistance to long-term senescence.

Douarre C, Gomez D, Morjani H, Zahm JM, O'donohue MF, Eddabra L, Mailliet P, Riou JF, Trentesaux C. Douarre C, et al. Among authors: morjani h. Nucleic Acids Res. 2005 Apr 14;33(7):2192-203. doi: 10.1093/nar/gki514. Print 2005. Nucleic Acids Res. 2005. PMID: 15831792 Free PMC article.

8

[Telomeres and telomerase, new targets for anticancer chemotherapy].

Riou JF, Morjani H, Trentesaux C. Riou JF, et al. Among authors: morjani h. Ann Pharm Fr. 2006 Mar;64(2):97-105. doi: 10.1016/s0003-4509(06)75301-9. Ann Pharm Fr. 2006. PMID: 16568010 Review. French.

9

Mechanism of acridine-based telomerase inhibition and telomere shortening.

Gunaratnam M, Greciano O, Martins C, Reszka AP, Schultes CM, Morjani H, Riou JF, Neidle S. Gunaratnam M, et al. Among authors: morjani h. Biochem Pharmacol. 2007 Sep 1;74(5):679-89. doi: 10.1016/j.bcp.2007.06.011. Epub 2007 Jun 16. Biochem Pharmacol. 2007. PMID: 17631279

10

Targeting human telomerase for cancer therapeutics.

Guittat L, Alberti P, Gomez D, De Cian A, Pennarun G, Lemarteleur T, Belmokhtar C, Paterski R, Morjani H, Trentesaux C, Mandine E, Boussin F, Mailliet P, Lacroix L, Riou JF, Mergny JL. Guittat L, et al. Among authors: morjani h. Cytotechnology. 2004 Jun;45(1-2):75-90. doi: 10.1007/s10616-004-5127-z. Cytotechnology. 2004. PMID: 19003245 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

130 results

Search Page